title: Intraocular pressure elevation and post-DMEK glaucoma following Descemet membrane endothelial keratoplasty.
abstract: OBJECTIVE
  Intraocular pressure (IOP) elevation and post-keratoplasty glaucoma occur commonly after penetrating keratoplasty (PK), but also after Descemet stripping endothelial keratoplasty (DSEK). In this study, we evaluated the risk after Descemet membrane endothelial keratoplasty (DMEK) to develop IOP elevation and post-DMEK glaucoma.
  
  
  METHODS
  The 12-month incidence of IOP elevation and post-DMEK glaucoma was analyzed retrospectively in the first 117 consecutive eyes that underwent DMEK between September 2011 and December 2012 at the Universitätsmedizin-Charité, Berlin. IOP elevation was defined as IOP ≥ 22 mmHg, or ≥10 mmHg from preoperative baseline. The assessment included the pre-operative history of corneal disease and glaucoma. Furthermore, the response to anti-glaucoma treatment, the graft failure, the IOP, the visual acuity, and the endothelial cell count were evaluated.
  
  
  RESULTS
  The 12-month incidence of IOP elevation was 12.10 % [95 % confidence interval (CI): 0.94 %, 18.37 %], post-DMEK glaucoma 2.7 % (95 % CI: -0.44 %, 5.84 %). The most frequent cause remained steroid-induced IOP elevation, with an 12-month incidence of 8.0 % (95 % CI: 7.95 %, 8.05 %). In all cases, IOP elevation was treated effectively by tapering down steroid medication and initiating or increasing anti-glaucoma medication. The incidence of postoperative postoperative pupillary block IOP elevation was 15.40 % (95 % CI: 8.93 %, 21.87 %). The number of eyes with iridocorneal contacts after surgery was low (4.2 %). Only the preoperative increased IOP is a significant risk factor for IOP elevation (p = 0.005). Visual acuity improved significantly after surgery (p < 0.001), and clear grafts were achieved in all eyes. Mean endothelial cell count did not differ between patients with and without IOP elevation.
  
  
  CONCLUSIONS
  Incidence of IOP elevation and post-keratoplasty glaucoma after DMEK were low, but regular IOP measurements, especially in eyes with pre-existing glaucoma and bullous keratopathy, are necessary. Steroid-induced IOP elevation was the most frequent reason, and could be treated effectively by tapering down steroid medication or changing the steroid drug. Development of peripheral anterior synechiae after DMEK occured rarely. Therefore, the risk for IOP elevation and especially post-DMEK keratoplasty was reduced compared to PK and DSEK. In all cases, successful management by medical treatment was possible, and resulted in good visual acuity.
authors.affiliation: Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum Augustenburger Platz 1, 13353, Berlin, Germany, anna-karina.maier@charite.de.
authors.forename: Anna-Karina B
authors.initials: AK
authors.lastname: Maier
authors.forename: Tina
authors.initials: T
authors.lastname: Wolf
authors.forename: Enken
authors.initials: E
authors.lastname: Gundlach
authors.forename: Matthias K J
authors.initials: MK
authors.lastname: Klamann
authors.forename: Johannes
authors.initials: J
authors.lastname: Gonnermann
authors.forename: Eckart
authors.initials: E
authors.lastname: Bertelmann
authors.forename: Antonia M
authors.initials: AM
authors.lastname: Joussen
authors.forename: Necip
authors.initials: N
authors.lastname: Torun
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002452:Cell Count; D003317:Corneal Dystrophies, Hereditary / Q000601:surgery; D057111:Descemet Stripping Endothelial Keratoplasty; D004728:Endothelium, Corneal / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000188:drug therapy / Q000209:etiology*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D014065:Tonometry, Ocular; D014792:Visual Acuity / Q000502:physiology
chemical_list: D005938:Glucocorticoids
references.citation: Am J Ophthalmol. 1981 Sep;92(3):372-7
references.pmid: 7027797
references.citation: Indian J Ophthalmol. 2008 Jul-Aug;56(4):269-77
references.pmid: 18579984
references.citation: Cornea. 2009 Aug;28(7):759-64
references.pmid: 19574912
references.citation: Am J Ophthalmol. 2012 May;153(5):958-966.e1
references.pmid: 22285014
references.citation: Ophthalmology. 2011 Dec;118(12):2368-73
references.pmid: 21872938
references.citation: Cornea. 2002 May;21(4):368-73
references.pmid: 11973385
references.citation: Cornea. 2010 Mar;29(3):278-82
references.pmid: 20118781
references.citation: Ophthalmology. 1987 Jul;94(7):871-4
references.pmid: 3309771
references.citation: Graefes Arch Clin Exp Ophthalmol. 1997 Sep;235(9):553-7
references.pmid: 9342604
references.citation: Surv Ophthalmol. 2000 Sep-Oct;45(2):91-105
references.pmid: 11033036
references.citation: Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):105-16
references.pmid: 22644096
references.citation: Trans Am Ophthalmol Soc. 1989;87:79-91; discussion 91-3
references.pmid: 2562533
references.citation: Eye (Lond). 1988;2 Suppl:S19-26
references.pmid: 3076147
references.citation: Cornea. 2006 Sep;25(8):987-90
references.pmid: 17102683
references.citation: Ophthalmology. 2009 Dec;116(12):2361-8
references.pmid: 19875170
references.citation: Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1191-8
references.pmid: 23180233
references.citation: Klin Monbl Augenheilkd. 2010 Jun;227(6):467-77
references.pmid: 20560100
references.citation: Ophthalmology. 2012 Mar;119(3):536-40
references.pmid: 22218143
references.citation: Cornea. 2009 May;28(4):385-94
references.pmid: 19411956
references.citation: Jpn J Ophthalmol. 2012 Jul;56(4):307-11
references.pmid: 22644449
references.citation: Am J Ophthalmol. 2012 Jun;153(6):1082-90.e2
references.pmid: 22397955
references.citation: Arq Bras Oftalmol. 2013 Oct;76(5):288-91
references.pmid: 24232942
references.citation: Am J Ophthalmol. 1993 Jun 15;115(6):711-4
references.pmid: 8506905
references.citation: Am J Ophthalmol. 2008 Feb;145(2):222-227
references.pmid: 18061137
references.citation: Graefes Arch Clin Exp Ophthalmol. 2010 Feb;248(2):237-42
references.pmid: 19936776
references.citation: Ophthalmology. 2010 Jul;117(7):1460-1; author reply 1461-2
references.pmid: 20609998
references.citation: Cornea. 2002 Apr;21(3):284-8
references.pmid: 11917177
references.citation: Acta Ophthalmol Scand. 2006 Dec;84(6):766-70
references.pmid: 17083535
references.citation: Ophthalmologe. 2012 Nov;109(11):1093-7
references.pmid: 22752628
references.citation: Am J Ophthalmol. 1983 Aug;96(2):160-4
references.pmid: 6349367
references.citation: J Cataract Refract Surg. 2008 Sep;34(9):1578-83
references.pmid: 18721723
references.citation: Klin Monbl Augenheilkd. 2012 Jun;229(6):615-20
references.pmid: 22752983
references.citation: Ophthalmology. 2009 Sep;116(9):1644-50
references.pmid: 19643499
references.citation: Ophthalmology. 2009 Sep;116(9):1818-30
references.pmid: 19643492
references.citation: Am J Ophthalmol. 2006 Jul;142(1):17-30
references.pmid: 16815247
references.citation: Invest Ophthalmol Vis Sci. 1977 Dec;16(12):1085-92
references.pmid: 336579